Gabelli Funds LLC Regeneron Pharmaceuticals, Inc. Transaction History

Gabelli Funds LLC

  • $12.8 Billion
  • Q3 2024

A detailed history of Gabelli Funds LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Gabelli Funds LLC holds 1,943 shares of REGN stock, worth $1.37 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,943
Previous 1,893 2.64%
Holding current value
$1.37 Million
Previous $1.99 Million 2.66%
% of portfolio
0.02%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$1024.09 - $1201.76 $51,204 - $60,088
50 Added 2.64%
1,943 $2.04 Million
Q2 2024

Aug 13, 2024
BUY
$883.2 - $1071.19 $30,028 - $36,420
34 Added 1.83%
1,893 $1.99 Million
Q1 2024

May 14, 2024
BUY
$902.69 - $993.35 $48,745 - $53,640
54 Added 2.99%
1,859 $1.79 Million
Q4 2023

Feb 13, 2024
BUY
$775.18 - $881.7 $197,670 - $224,833
255 Added 16.45%
1,805 $1.59 Million
Q2 2022

Aug 12, 2022
SELL
$548.35 - $738.84 $154,634 - $208,352
-282 Reduced 15.39%
1,550 $916,000
Q1 2022

May 13, 2022
SELL
$595.12 - $698.43 $3.81 Million - $4.47 Million
-6,400 Reduced 77.75%
1,832 $1.28 Million
Q4 2021

Feb 11, 2022
SELL
$543.48 - $670.97 $217,392 - $268,388
-400 Reduced 4.63%
8,232 $5.2 Million
Q3 2021

Nov 12, 2021
SELL
$574.03 - $680.96 $229,612 - $272,384
-400 Reduced 4.43%
8,632 $5.22 Million
Q2 2021

Aug 13, 2021
BUY
$472.8 - $558.54 $2,364 - $2,792
5 Added 0.06%
9,032 $5.05 Million
Q1 2021

May 14, 2021
BUY
$446.73 - $548.2 $3.25 Million - $3.99 Million
7,282 Added 417.31%
9,027 $4.27 Million
Q3 2020

Nov 06, 2020
SELL
$544.75 - $658.21 $13,618 - $16,455
-25 Reduced 1.41%
1,745 $977,000
Q2 2020

Aug 13, 2020
SELL
$493.32 - $643.92 $76,464 - $99,807
-155 Reduced 8.05%
1,770 $1.1 Million
Q1 2020

May 14, 2020
BUY
$336.18 - $494.43 $109,258 - $160,689
325 Added 20.31%
1,925 $940,000
Q4 2019

Feb 14, 2020
SELL
$274.13 - $376.51 $137,065 - $188,255
-500 Reduced 23.81%
1,600 $601,000
Q4 2018

Jan 30, 2019
SELL
$335.82 - $403.04 $134,328 - $161,216
-400 Reduced 16.0%
2,100 $784,000
Q2 2018

Aug 10, 2018
BUY
$284.6 - $344.99 $199,220 - $241,493
700 Added 38.89%
2,500 $862,000
Q1 2018

May 09, 2018
BUY
$315.82 - $393.78 $252,656 - $315,024
800 Added 80.0%
1,800 $620,000
Q4 2017

Feb 02, 2018
SELL
$358.63 - $469.95 $2.08 Million - $2.73 Million
-5,800 Reduced 85.29%
1,000 $376,000
Q3 2017

Nov 01, 2017
BUY
$431.38 - $504.0 $2.93 Million - $3.43 Million
6,800
6,800 $3.04 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Gabelli Funds LLC Portfolio

Follow Gabelli Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email